| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |